1. Academic Validation
  2. A first exon termination checkpoint preferentially suppresses extragenic transcription

A first exon termination checkpoint preferentially suppresses extragenic transcription

  • Nat Struct Mol Biol. 2021 Apr;28(4):337-346. doi: 10.1038/s41594-021-00572-y.
Liv M I Austenaa # 1 Viviana Piccolo # 2 Marta Russo # 2 Elena Prosperini 2 Sara Polletti 2 Danilo Polizzese 2 Serena Ghisletti 2 Iros Barozzi 3 Giuseppe R Diaferia 2 Gioacchino Natoli 4 5
Affiliations

Affiliations

  • 1 European Institute of Oncology (IEO) IRCCS, Milan, Italy. [email protected].
  • 2 European Institute of Oncology (IEO) IRCCS, Milan, Italy.
  • 3 Department of Surgery and Cancer, Imperial College London, London, UK.
  • 4 European Institute of Oncology (IEO) IRCCS, Milan, Italy. [email protected].
  • 5 Humanitas University (Hunimed), Milan, Italy. [email protected].
  • # Contributed equally.
Abstract

Interactions between the splicing machinery and RNA polymerase II increase protein-coding gene transcription. Similarly, exons and splicing signals of enhancer-generated long noncoding RNAs (elncRNAs) augment enhancer activity. However, elncRNAs are inefficiently spliced, suggesting that, compared with protein-coding genes, they contain qualitatively different exons with a limited ability to drive splicing. We show here that the inefficiently spliced first exons of elncRNAs as well as promoter-antisense long noncoding RNAs (pa-lncRNAs) in human and mouse cells trigger a transcription termination checkpoint that requires WDR82, an RNA polymerase II-binding protein, and its RNA-binding partner of previously unknown function, ZC3H4. We propose that the first exons of elncRNAs and pa-lncRNAs are an intrinsic component of a regulatory mechanism that, on the one hand, maximizes the activity of these cis-regulatory elements by recruiting the splicing machinery and, on the other, contains elements that suppress pervasive extragenic transcription.

Figures